Home PageCompanyStrategy

Strategy

Velos brings together scattered drug development projects, resources and markets, then creates global synergies by unlocking their combined value.

In Asia, we have aggregated disparate markets and scattered drug development capabilities to synthesize a pan-Asian model with scale, flexibility and depth. This enables our U.S. and European pharmaceutical partners to most effectively implement their broad Asia strategies.

In the U.S. and Europe, our active licensing efforts are building a portfolio of new drugs that address the unmet medical needs of patients across Asia.

Implementing the Process

We manage every stage of the pan-Asian commercialization process. For each product, in each territory, we mobilize the appropriate resources to evaluate market conditions, complete clinical development if required, expedite registration, and develop an actionable marketing plan. Given our focus on addressing unmet medical needs, our particular competency is in creating and developing new markets.

Developing Best Practices

The multitude of territories we cover presents us with the full spectrum of drug development and commercialization challenges. From this dynamic proving ground, we continually develop the best practices for our partners in the U.S., Europe and Asia.